Concord Medical Services

Concord Medical Services Holdings Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. It provides radiotherapy and diagnostic equipment leasing services to hospitals; and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals, It operates through Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. It operates through Network Business and Hospital Business segments. It provides radiotherapy and diagnostic equipment leasing services to hospitals, and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

BEIJING , Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that the National Medical Products Administration of the People's Republic of China has granted approval to the application for the Registration Certificate for Medical Device for the proton therapy equipment (the "Registration Certificate") made by the Company's equipment supplier on December 6, 2024. As previously disclosed in the Company's annual report for the fiscal year ended December 31, 2023, Guangzhou Concord Cancer Center ("Guangzhou Hospital"), a PRC subsidiary of the Company offering comprehensive cancer care services, has completed the installment of the proton equipment in September 2020 and commenced its clinical trial in November 2022.

Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

BEIJING , Nov. 13, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it will hold its 2024 annual general meeting of shareholders (the "Meeting") on December 27, 2024, at 10:00 a.m. (Beijing Time).

Concord Medical Schedules 2024 Annual Meeting of Shareholders

BEIJING , Sept. 27, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2024 [1].

Concord Medical Reports Financial Results for the First Half of 2024

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM #drilling--Canagold Resources Ltd. (“Canagold” or the “Company”) (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) announces sample assay results from an additional 2 drill holes from the resource expansion drill program targeting the North Zone at its 100% owned New Polaris Gold project located in northwestern British Columbia, 100 kilometers (km) south of Atlin and 60 km northeast of Juneau, Alaska. Details of the holes are shown in Table 1. Highlights 10.8 grams p.

Canagold Completes Resource Expansion Drilling Program at New Polaris with Additional Strong Mineralization Intercepts

BEIJING , Sept. 16, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that Guangzhou Concord Cancer Center ("Guangzhou Hospital"), a PRC subsidiary of the Company offering comprehensive cancer care services, has obtained the large medical equipment procurement license (the "License") for its proton equipment.

Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (“Canagold” or the “Company”) (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA), announces sample assay results from an additional 26 drill holes from the resource expansion drill program targeting the North Zone at its 100% owned New Polaris Gold project located in northwestern British Columbia, 100 kilometers (km) south of Atlin and 60 km northeast of Juneau, Alaska. Highlights of the gold mineralization that was intersected are s.

Canagold Continues to Intercept Strong Mineralization in Resource Expansion Drilling Program at New Polaris

BEIJING , Aug. 7, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter from the New York Stock Exchange ("NYSE") dated August 6, 2024 (the "Compliance Notice"), notifying the Company that it is no longer considered below the NYSE's continued listing criterion of a minimum average share price of US$1.00 over a 30 trading-day period (the "NYSE Minimum Price Requirement"). As previously announced, the Company received a letter from the NYSE dated February 12, 2024, notifying the Company that it was below compliance standards due to the trading price of its American Depositary Shares.

Concord Medical Regains Compliance with NYSE Minimum Price Requirement

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) announces sample assay results from the first five drill holes from the resource expansion drill program targeting the North Zone at its 100% owned New Polaris Gold project located in northwestern British Columbia, 100 kilometers (km) south of Atlin and 60 km northeast of Juneau, Alaska. Highlights of the gold mineralization that was intersected in the initial five drill holes are sh.

Canagold Intercepts Strong Mineralization in First Five Resource Expansion Drill Holes at New Polaris

BEIJING , July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to Class A ordinary shares (the "ADS Ratio") from the current ADS Ratio of one (1) ADS representing three (3) Class A ordinary shares to a new ADS Ratio of one (1) ADS representing thirty (30) Class A ordinary shares. The Company anticipates that the change in the ADS Ratio will be effective on July 30, 2024 (U.S. Eastern Time).

CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the “Company”) announces that at its annual general meeting of shareholders held on June 12, 2024 (the “Meeting”), all directors listed in the Information Circular dated May 9, 2024 were elected. The detailed results are as follows: Nominee Director Votes For % Votes For Votes Withheld % Votes Withheld Sofia Bianchi 93,941,380 99.46 511,258 0.54 Kadri Dagdelen 94,112,959 99.64 339,6.

Canagold Resources Ltd. Announces Voting Results From Annual General Meeting

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the “Company” or “Canagold”), is pleased to announce that, in line with its commitment to accelerating the advancement of the New Polaris Gold project towards production, drill crews have been mobilized to the site in northern British Columbia to restart drilling operations. The 2024 drilling program includes 12,000 meters of drilling, primarily targeting high-grade mineralization a.

Canagold Initiates Resource Expansion Drilling at New Polaris Project

BEIJING , April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov.

Concord Medical Files 2023 Annual Report on Form 20-F

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the "Company" or "Canagold"), is pleased to announce it has closed a charity flow-through financing with Sun Valley Investments AG (“Sun Valley”). The Company issued 15,700,000 common shares of the Company (the “FT Share”) that qualify as flow-through shares for the purposes of the Income Tax Act (Canada) at a price of $0.2625 per FT Share for total gross proceeds of $4,121,500 (the.

Canagold Resources Ltd. Announces Closing of $4.1M Charity Flow Through Financing

BEIJING , Feb. 20, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure period for the Company to regain compliance expires on August 12, 2024. Pursuant to applicable NYSE continued listing standards, a company would be considered "below criteria" by the NYSE if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period.

Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

BEIJING , Jan. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced the listing of a minority stake of 39,420,200 H shares in Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), its subsidiary, at an initial public offer price of HK$14.28 per H share on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK.

Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) announces today that the Company has appointed Mr. Chris Pharness as Senior Vice President Sustainability and Permitting, effective immediately. Mr. Pharness has 30 years of experience as an Environmental Professional. He has a proven record of success in community engagement, relationship building and negotiation, and demonstrated achievement in project.

Canagold Appoints Chris Pharness as Senior Vice President Sustainability and Permitting

BEIJING , Nov. 20, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2023 annual general meeting of shareholders (the "Meeting") on December 26, 2023, at 10:00 a.m. (Beijing Time).

Concord Medical Schedules 2023 Annual Meeting of Shareholders

BEIJING , Sept. 22, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023 [1].

Concord Medical Reports Financial Results for the First Half of 2023

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) has filed a technical report titled “The New Polaris Gold Project, British Columbia, Canada 2023 Resource Estimate Update” prepared in accordance with National Instrument 43-101 -- Standards of Disclosure for Mineral Projects. The technical report is in support of the company's May 16, 2023, news release announcing the results of a mineral resource estim.

Canagold Files NI 43-101 Technical Report for New Polaris Mineral Resource Estimate

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the “Company”) announces that at its annual general and special meeting of shareholders held on June 19, 2023 (the “Meeting”), all directors nominated listed in the Information Circular dated May 17, 2023 were elected. The detailed results are as follows: Nominee Director   Votes For   % Votes For   Votes Withheld   % Votes Withheld Sofia Bianchi   73,489,301   91.33   6,972,287   8.

Canagold Resources Ltd. Announces Voting Results From Annual General and Special Meeting

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) is pleased to announce the company has appointed Mr. Tim Caldwell as the Company's Vice President, Sustainability. Mr. Caldwell has over 25 years of experience in the province of British Columbia and around the globe having worked for companies such as: Teck Resources, Anglo American, Centerra Gold and most recently Kinross Gold. His career has taken him.

Canagold Appoints Vice President, Sustainability

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) is pleased to announce an in-person open house for the entire Taku River Tlingit First Nation citizenship being held at the Atlin Community Centre, 217 Sinclair Ave, Atlin, B.C , to discuss the major components of the New Polaris project, where they will be located, and anticipated interactions with the surrounding environment and existing human activiti.

Canagold, Taku River Tlingit First Nation to Host Open House for Proposed Permitting of New Polaris Gold Project

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) is pleased to announce the Updated Mineral Resource Estimate for New Polaris Gold Project located approximately 100 kilometres south of Atlin, BC. Underground Mineral Resource Estimate (MRE): 2.97 million tonnes (Mt)@ 11.6 grams per tonne gold (gpt Au) for 1.11 million ounces (Moz) contained gold Indicated and 0.93 Mt @ 8.93 gpt Au for 0.27 Moz contained.

Canagold Increases Indicated Gold Resource by 89% in Updated Mineral Resource Estimate for New Polaris Gold Project, BC

BEIJING , April 19, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov.

Concord Medical Files 2022 Annual Report on Form 20-F

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (“Canagold” or the “Company”) is pleased to announce the appointment of Mr. Colm Keogh as Senior Vice President, Operations. Mr. Keogh is a Professional Mining Engineer with 30 years of experience in underground hard-rock mining across Canada and the United States, in Europe, Mexico, South America and Africa.

News for Concord Medical Services Stock (CCM)